|
||||||||||||||||||||||||||
| SEC Info℠ | | | Home | | | Search | | | My Interests | | | Help | | | Sign In | | | Please Sign In | |||||||
|
||||||||||||||||||||||||||
As Of Filer Filing For·On·As Docs:Size Issuer Agent 3/18/14 Lipocine Inc. 8-A12B 1:17K Toppan Vintage/FA |
Document/Exhibit Description Pages Size 1: 8-A12B Registration of a Class of Securities HTML 14K
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-A
FOR REGISTRATION OF CERTAIN CLASSES
OF SECURITIES
PURSUANT TO SECTION 12(b) OR 12(g) OF THE
SECURITIES EXCHANGE ACT OF 1934
| Lipocine Inc. |
| (Exact name of registrant as specified in its charter) |
| Delaware | 99-0370688 | |
| (State of incorporation or organization) | (I.R.S. Employer Identification No.) |
| 675 Arapeen Drive, Suite 202; Salt Lake City, Utah | 84108 |
| (Address of principal executive offices) | (Zip Code) |
Securities to be registered pursuant to Section 12(b) of the Act:
| Title of each class to be so registered |
Name of each exchange on which each class is to be registered |
| Common Stock, par value $0.0001 per share | The NASDAQ Stock Market LLC | |
If this form relates to the registration of a class of securities pursuant to Section 12(b) of the Exchange Act and is effective pursuant to General Instruction A.(c), check the following box. þ
If this form relates to the registration of a class of securities pursuant to Section 12(g) of the Exchange Act and is effective pursuant to General Instruction A.(d), please check the following box. ¨
| Securities Act registration statement file number to which this form relates: | (if applicable) |
Securities to be registered pursuant to Section 12(g) of the Act:
None
(Title of Class)
(Title of Class)
C:
INFORMATION REQUIRED IN REGISTRATION STATEMENT
Item 1. Description of Registrant’s Securities to be Registered.
This registration statement relates to the registration with the Securities and Exchange Commission of shares of Common Stock, par value $0.0001 per share (the “Common Stock”), of Lipocine Inc., a Delaware corporation (the “Registrant”). The description of the Common Stock set forth under the caption “Description of Capital Stock” in the Registrant’s Registration Statement on Form S-1 (File No. 333-192069) originally filed with the Securities and Exchange Commission on November 4, 2013 and as subsequently amended, together with the description set forth under such caption included in the form of prospectus subsequently filed by the Registrant with the Securities and Exchange Commission pursuant to Rule 424(b) under the Securities Act of 1933, as amended, is incorporated herein by this reference in response to this item.
Item 2. Exhibits.
None.
C:
| C: 2 |
SIGNATURE
Pursuant to the requirements of Section 12 of the Securities Exchange Act of 1934, the Registrant has duly caused this registration statement to be signed on its behalf by the undersigned, thereunto duly authorized.
| (Registrant) | LIPOCINE INC. |
| Date | March 18, 2014 |
| By | /s/ Mahesh V. Patel |
| Mahesh V. Patel President and Chief Executive Officer |
C:
| 3 |
| This ‘8-A12B’ Filing | Date | Other Filings | ||
|---|---|---|---|---|
 | ||||
| Filed on: | 3/18/14 | 424B3, 8-K | ||
| 11/4/13 | S-1 | |||
| List all Filings | ||||
As Of Filer Filing For·On·As Docs:Size Issuer Filing Agent 4/26/24 Lipocine Inc. 424B5 1:456K M2 Compliance LLC/FA 4/23/24 Lipocine Inc. S-3/A 3:763K M2 Compliance LLC/FA 11/22/23 Lipocine Inc. S-3 6:1.5M M2 Compliance LLC/FA 1/27/21 Lipocine Inc. 424B5 1:486K Toppan Merrill/FA 1/25/21 Lipocine Inc. 424B5 1:488K Toppan Merrill/FA 11/13/20 Lipocine Inc. S-3 6:1.1M Toppan Merrill/FA 8/21/20 Lipocine Inc. 424B5 1:383K Toppan Merrill/FA |